aprindine has been researched along with cifenline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, R; Koide, M; Miyahara, T; Sotobata, I; Toyama, J; Ukai, M; Yasui, S; Yokota, M | 1 |
| Hasegawa, J; Hirokane, Y; Kotake, H; Mashiba, H; Nawada, T; Noguchi, N | 1 |
| Somberg, J | 1 |
| Furuya, H; Goto, Y; Tanabe, T; Yoshikawa, H | 1 |
| Heger, JJ; Prystowsky, EN; Zipes, DP | 1 |
| Hiraoka, M; Inoue, H; Kasanuki, H; Kato, T; Kodama, I; Mitamura, H; Ogawa, S; Sugimoto, T | 1 |
| Imai, H; Matoba, Y; Nakagawa, M; Shiraishi, H; Shirayama, T; Yoshida, S | 1 |
| Abe, N; Horiuchi, D; Kameda, K; Komatsu, T; Nakamura, S; Oikawa, K; Okumura, K; Owada, S; Suzuki, O; Tomita, H; Yomogida, K | 1 |
2 review(s) available for aprindine and cifenline
| Article | Year |
|---|---|
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian Gambit. The Guideline Committee for Clinical Use of Antiarrhythmic Drugs in Japan (Working Group of Arrhythmias of the Japanese Society of Electrocardiology).
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Humans; Imidazoles; Lidocaine; Piperidines | 1999 |
6 other study(ies) available for aprindine and cifenline
| Article | Year |
|---|---|
[Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
Topics: Administration, Oral; Anti-Arrhythmia Agents; Aprindine; Flecainide; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone | 1992 |
Transient increase in the contractile force induced by antiarrhythmic drugs in guinea pig cardiac muscles.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Disopyramide; Guinea Pigs; Imidazoles; In Vitro Techniques; Myocardial Contraction; Quinidine | 1989 |
Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Chronic Disease; Disopyramide; Drug Therapy, Combination; Female; Heart Ventricles; Humans; Imidazoles; Male; Mexiletine; Middle Aged | 1988 |
Drug therapy of cardiac arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availability; Encainide; Half-Life; Humans; Imidazoles; Intestinal Absorption; Kinetics; Lidocaine; Metabolic Clearance Rate; Mexiletine; Propafenone; Propiophenones; Protein Binding; Tachycardia; Tocainide | 1983 |
Atrial fibrillation threshold predicted long-term efficacy of pharmacological treatment of patients without structural heart disease.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Disopyramide; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Treatment Outcome | 2002 |
[Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Autonomic Nervous System; Circadian Rhythm; Disopyramide; Female; Humans; Imidazoles; Male; Middle Aged | 2003 |